Windham Venture Partners

@windhamvp

November 30, 2015

Invuity Names Greg Lucier Chairman

SAN FRANCISCO (GLOBE NEWSWIRE) — Invuity, Inc. (IVTY), an advanced medical technology company, announced today that life sciences industry luminary Gregory T. Lucier has been appointed to the role of … Continued

November 20, 2015

New Phase 3 Data show Optune in Combination with Second Line Chemotherapy is Superior to Second Line Chemotherapy Alone in Glioblastoma Patients at First Recurrence

St. Helier, Jersey – Novocure (NASDAQ: NVCR), announced today new Phase 3 data showing that glioblastoma patients who received TTFields in combination with chemotherapy at first recurrence lived significantly longer … Continued

Archives

© 2024 Windham Venture Partners 500 Fifth Avenue, Suite 3600, NY, NY 10110